Trial intelligence / Profile preview

Anesthesia Maintenance Protocols in Urinary Surgery

NCT04443946Phase 4Completed

Sponsor
China International Neuroscience Institute
Start
Jun 2020
Primary completion
Aug 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of propofol, sevoflurane and sufentanil in general anesthesia (5 arms), sponsored by China International Neuroscience Institute. Primary endpoint: Extubation Duration up to 24 hours. Started Jun 2020; status: completed.

02

Drugs

propofolsevofluranesufentanil
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT04443946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04443946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call